List of titles

List of titles Pricing and reimbursement

You are on page 1 of 97
We found 2422 results for your search

AIFA updates the Transparency Lists Highlights News

AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 15 May 2024.

Wed May 15 00:00:00 CEST 2024 Pricing and reimbursement > Transparency Lists

Modifica Registro JEMPERLI secondo Legge 648/96

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che  è stato aggiornato il Registro di Jemperli (dostarlimab) dedicato al monitoraggio di una specifica indicazione rimborsata ai sensi della L. 648/1996.

Mon May 13 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Hepatitis C: update of 6 May 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Wed May 08 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Scientific development of data from AIFA monitoring registries Highlights News

Data from the Italian Medicines Agency's Monitoring Registries on various oncological drugs were analysed in a study entitled "Comparison of baseline characteristics of patients in Italian monitoring registries of oncological drugs and registrative clinical trials: a cross-sectional real-world study", published in the journal The Lancet Regional Health - Europe.

Mon May 06 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Hepatitis C: update of 29 April 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Thu May 02 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Modifica Registro - anticorpi monoclonali COVID-19

Si informano gli utenti dei Registri Farmaci sottoposti a Monitoraggio che, dal 25/04/2024 non sarà possibile la prescrizione dell’anticorpo monoclonale sotrovimab, per il trattamento di COVID-19.

Tue Apr 30 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

List of class A and H medicinal products at 15 November 2023 Highlights News

AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.

Mon Apr 29 00:00:00 CEST 2024 Pricing and reimbursement > Lists of Class A and Class H medicinal products

Hepatitis C: update of 22 April 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Tue Apr 23 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Farmaci per il trattamento del diabete mellito tipo 2: aggiornata la tabella B della Nota 100 Highlights News

Le modifiche introdotte sono successive all'aggiornamento dell'RCP di empagliflozin per quanto riguarda l'uso nella compromissione renale.

Wed Apr 17 00:00:00 CEST 2024 Pricing and reimbursement > AIFA Notes

Hepatitis C: update of 15 April 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Tue Apr 16 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

AIFA updates the Transparency Lists Highlights News

AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 16 April 2024.

Tue Apr 16 00:00:00 CEST 2024 Pricing and reimbursement > Transparency Lists

Aggiornamento Registro MULTIFARMACO PPP, per i farmaci sottoposti a programma di prevenzione della gravidanza

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che il Registro Multifarmaco PPP (Programma di Prevenzione della Gravidanza) è aggiornato con l’inserimento di medicinali generici della lenalidomide.

Mon Apr 15 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Modifica Registro VYVGART

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che è stato aggiornato il Registro di VYVGART dedicato al monitoraggio di una specifica indicazione terapeutica.

Wed Apr 10 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Differiti fino all'8 luglio 2024 gli effetti della determina AIFA istitutiva della Nota 101 Highlights News

 Fino all'8 luglio 2024 restano applicabili le modalità prescrittive e di erogazione vigenti anteriormente alla istituzione della nota.

Tue Apr 09 00:00:00 CEST 2024 Pricing and reimbursement > AIFA Notes

Hepatitis C: update of 8 April 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Tue Apr 09 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Innovative medicines list: AIFA publishes March 2024 update Highlights News

AIFA updates the list of medicines that, in the opinion of the Scientific and Technical Committee (CTS), meet the requirement of full or conditional therapeutic innovativeness.

Tue Apr 09 00:00:00 CEST 2024 Pricing and reimbursement > Innovative medicinal products

Hepatitis C: update of 1 April 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Thu Apr 04 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

Aggiornamento Registro MULTIFARMACO PPP, per i farmaci sottoposti a programma di prevenzione della gravidanza

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che il Registro Multifarmaco PPP (Programma di Prevenzione della Gravidanza) è aggiornato con l’inserimento di medicinali generici della lenalidomide.

Tue Apr 02 00:00:00 CEST 2024 Pricing and reimbursement > Monitoring Registers

List of class A and H medicinal products at 16 October 2023 Highlights News

AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.

Fri Mar 29 00:00:00 CET 2024 Pricing and reimbursement > Lists of Class A and Class H medicinal products

Termine del monitoraggio BLENREP

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che, a partire dal 27/03/2024 termina il monitoraggio dei trattamenti in corso nel Registro BLENREP per una specifica indicazione terapeutica.

Wed Mar 27 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Hepatitis C: update of 25 March 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Wed Mar 27 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Modifica Registro ZEJULA

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che, a partire dal 23/03/2024 sarà possibile utilizzare per due indicazioni di ZEJULA: monoterapia.

Mon Mar 25 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Hepatitis C: update of 18 March 2024 concerning enrolled patients Highlights News

AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.

Thu Mar 21 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Attivazione web e pubblicazione schede di monitoraggio - Registro FILSUVEZ

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che, a partire dal 16/03/2024 è possibile utilizzare, in regime di rimborsabilità SSN, il medicinale FILSUVEZ per una specifica indicazione terapeutica.

Mon Mar 18 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Attivazione web e pubblicazione schede di monitoraggio - Registro COLUMVI

Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che, a partire dal 16/03/2024 è possibile utilizzare, in regime di rimborsabilità SSN, il medicinale COLUMVI per una specifica indicazione terapeutica.

Mon Mar 18 00:00:00 CET 2024 Pricing and reimbursement > Monitoring Registers

Search filters Expand all Reset filters

  • Type

    • News
    • Event
    • Editorial content
    • Documents and procedures
    • Note AIFA
    • Multimedia
    • Organisation
    • Documents
    • Page

  • Publication date

  • Category

    • Access to medicinal products
    • Open governance
    • Companies Section
    • Consumption and pharmaceutical expenditure
    • COVID-19 emergency 
    • Information and communication
    • Innovation and planning
    • The Agency
    • Pricing and reimbursement
    • Quality and Inspections
    • Research and clinical trials
    • Safety of medicinal products

  • Other filters